Understanding MGUS, Its Progression Risks, and More image

Understanding MGUS, Its Progression Risks, and More

Aug 15, 2024
01:00PM - 02:00PM EDT
Online Event
Overview
An MGUS diagnosis can be hard to navigate, and often leaves more questions than answers. While often benign, MGUS can progress to active Multiple Myeloma. Dr. Adeel Khan joins us to help answer some of your most pressing questions around the diagnosis itself, along with progression risks, and more.

 

Highlights
Agenda
1:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Dr. Adeel Khan

1:05 PM
Presentation
Dr. Adeel Khan

Dr. Adeel Khan answers questions about MGUS.

1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Cynthia Cahoon, RN

Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Healthtree contact Dr. Adeel Khan

Dr. Adeel Khan

Dr. Khan earned his medical degree with special distinction at the University of Michigan in Ann Arbor, Michigan, while also obtaining a master’s degree in public health from Harvard University. He performed a residency in internal medicine at the Cleveland Clinic and Lerner College of Medicine in Cleveland, Ohio. After serving as a hospitalist at Massachusetts General Hospital and an instructor at Harvard Medical School and concurrently obtaining a master's degree in epidemiology from Columbia University, he gained advanced training in hematology and oncology through a fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently an Assistant Professor of Medicine and Public Health at UT Southwestern Medical Center where he serves as the Director of Myeloma Epidemiology Research and Clinical Director of the Monoclonal Gammopathy Precursor Clinic.